Syncom Formulations India Profit & Loss Annual

BSE: 524470 | NSE: SYNCOMF | ISIN: INE312C01025 | Sector: Biotechnology & Drugs

19.58 +0.07 (0.36%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	263.39	224.25	219.66	244.81
Total Revenue	263.39	224.25	219.66	244.81
Costof Revenue Total	156.88	146.66	140.54	161.46
Gross Profit	106.51	77.60	79.12	83.34
Selling/ General/ Admin Expenses Total	35.06	29.28	22.16	19.67
Depreciation/ Amortization	4.72	4.54	3.95	4.03
Unusual Expense( Income)	0.02	1.36	-	-
Other Operating Expenses Total	41.80	23.71	37.50	25.84
Total Operating Expense	238.49	205.55	204.15	211.00
Operating Income	24.90	18.70	15.51	33.80
Interest Inc( Exp) Net- Non- Op Total	-44.74	58.50	-11.63	-0.95
Other Net	13.53	2.00	11.80	6.97
Net Income Before Taxes	33.95	26.57	26.18	40.70
Provisionfor Income Taxes	8.64	6.50	6.39	11.53
Net Income After Taxes	25.31	20.07	19.79	29.17
Net Income Before Extra Items	25.31	20.07	19.79	29.17
Net Income	25.31	20.07	19.79	29.17
Income Availableto Com Excl Extra Ord	25.31	20.07	19.79	29.17
Income Availableto Com Incl Extra Ord	25.31	20.07	19.79	29.17
Diluted Net Income	25.31	20.07	19.79	29.17
Diluted Weighted Average Shares	74.45	92.85	87.32	79.00
Diluted EPS Excluding Extra Ord Items	0.34	0.22	0.23	0.37
Diluted Normalized EPS	0.34	0.23	0.23	0.37
Gain( Loss)on Saleof Assets	-	0.13	0.24	0.30
DPS- Common Stock Primary Issue	-	0.00	0.03	-
Dilution Adjustment	-	-	0.00	-